Rates of recurrent VTE or VTE-related death were similar between apixaban- and enoxaparin/warfarin-treated patients across body weight categories (Pinteraction = .44)
| Body weight category | Apixaban n/N |
Enoxaparin/Warfarin n/N |
RR (95% CI) | P interaction |
|
|---|---|---|---|---|---|
| ≤60 kg | 6/225 | 10/232 |
|
0.63 (0.23-1.72) | .44 |
| >60 kg to <100 kg | 42/1870 | 43/1892 |
|
0.99 (0.65-1.50) | |
| ≥100 kg to <120 kg | 10/368 | 13/366 |
|
0.77 (0.34-1.72) | |
| ≥120 kg | 1/141 | 5/142 |
|
0.20 (0.02-1.72) |
Favors apixaban
Favors enoxaparin/warfarin
